人源类器官的研究进展及在口腔医学的展望

doi:10.3877/cma.j.issn.1674-1366.2019.02.001

中华口腔医学研究杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 65 -70. doi: 10.3877/cma.j.issn.1674-1366.2019.02.001

所属专题：口腔医学；文献；

中青年专家笔谈

人源类器官的研究进展及在口腔医学的展望

谭汝铿¹, 曾润玲¹, 王卓然¹, 徐萌¹^,^†(

)

^1. 中山大学光华口腔医学院·附属口腔医院，广东省口腔医学重点实验室，广州　510055

收稿日期:2019-01-04 出版日期:2019-04-01
通信作者: 徐萌

The research progress of human organoids and the prospects of application in stomatology

Rukeng Tan¹, Runling Zeng¹, Zhuoran Wang¹, Meng Xu¹^,^†()

^1. Guanghua School of Stomatology, Hospital of Stomatology, Guangdong Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou 510055, China

Received:2019-01-04 Published:2019-04-01
Corresponding author: Meng Xu
About author:
Corresponding author: Xu Meng, Email: xumeng23@mail.sysu.edu.cn
Supported by:
Project supported by The National Natural Science Funds(81602384); 2018 Teaching reform and teaching quality plan-undergraduate practice teaching base construction project—Stomatological undergraduate practice teaching base of Sun Yat-sen University(52000-31911004); 2017 Teaching reform and teaching quality plan of Sun Yat-sen University (The application of self-made cutting machine to make ground tooth section in oral pathology lab); National Undergraduate Students Innovation Training Program(201810558159)

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

谭汝铿, 曾润玲, 王卓然, 徐萌. 人源类器官的研究进展及在口腔医学的展望[J/OL]. 中华口腔医学研究杂志(电子版), 2019, 13(02): 65-70.

Rukeng Tan, Runling Zeng, Zhuoran Wang, Meng Xu. The research progress of human organoids and the prospects of application in stomatology[J/OL]. Chinese Journal of Stomatological Research(Electronic Edition), 2019, 13(02): 65-70.

类器官是指在体外三维培养构建的，依赖于人造细胞外基质的多细胞团，具有自我更新、自我组织能力，并维持了其来源组织的生理结构和功能。类器官作为一种新兴的研究模型，兼具细胞系和动物模型两者的优点。其构建材料简单、培养效率高、耗时短，在疾病研究模型构建、临床药敏试验和再生医学中有良好的应用前景。类器官模型主要分为三种细胞来源类型：胚胎干细胞/诱导多能干细胞、成体干细胞、肿瘤细胞。本文将重点介绍三种细胞来源类器官最新的研究进展，并展望其在口腔医学中的应用。

关键词: 类器官, 胚胎干细胞, 诱导多能干细胞, 成体干细胞, 肿瘤

The organoid is a multicellular mass with the ability of self-renewal and self-organization in artificial extracellular matrix, which is constructed by three-dimensional culture in vitro, and it maintains the physiological structure and function of its source tissues. As a new research model, the organoid has the advantages of both cell lines and animal models. The easily material construction, high culturing efficiency and short time-consuming make it good application prospects in disease research model construction, clinical drug sensitivity test and regenerative medicine application. The organoid models can be divided into three types of cell sources: embryonic stem cells/induced pluripotent stem cells, adult stem cells and cancer cells. In this review, organoid from three cell sources will be elaborated separately, and mainly focused on the current status of human organoid research progress and the prospect of application in stomatology.

Key words: Organoid, Embryonic stem cells, Induced pluripotent stem cells, Adult stem cells, Neoplasms

图1 胚胎干细胞、诱导性多能干细胞来源的类器官培养过程

图2 已成功构建的成体干细胞来源的类器官

表1 胚胎干细胞、诱导多能干细胞来源的类器官构建材料

组织类型	组织来源	胚层分化培养基	器官分化培养基	类器官生长培养基
肠^[5]	人源胚胎干细胞和诱导性多能干细胞	含有Activin A的RPMI 1640培养基	含有成纤维细胞生长因子4、 CHIR99021的RPMI 1640培养基	含有表皮细胞生长因子、头蛋白、R-spondin1的高级DMEM/F12培养基、Matrigel
胃^[6]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin A、BMP4的RPMI 1640培养基	WNT3A、CHIR99021、成纤维细胞生长因子4、头蛋白、维甲酸的RPMI 1640培养基	含有表皮细胞生长因子、头蛋白、维甲酸的高级DMEM/F12培养基、 Matrigel
肝脏^[7]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin A、BMP4、CHIR 99021、成纤维细胞生长因子2、 LY294002的DMEM/F12培养基	含有成纤维细胞生长因子10、 BMP4的RPMI及B27培养基	含有肝细胞生长因子、抑瘤素M的高级DMEM/F12培养基、Matrigel
脑^[8]	人源胚胎干细胞和诱导性多能干细胞系	含有endo-IWR1、LDN-193189、 SB431542、β-巯基乙醇的KSR培养基	含有NEAA、BDNF、GDNF的neurobasal-type differentiation培养基、Matrigel	DMEM/F12培养基、Matrigel
肾^[9]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin的高级RPMI培养基	含有成纤维细胞生长因子9、 CHIR99021的高级RPMI培养基	含有CHIR99021、头蛋白、成纤维细胞生长因子9的高级RPMI 1640培养基
肺^[10]	人源胚胎干细胞系	含有Activin A、BMP4的DMEM/ F12培养基	含有成纤维细胞生长因子7，CHIR - 99021、维甲酸的DMEM/ F12培养基	DMEM/F12培养基、Matrigel
乳腺^[11]	人源诱导性多能干细胞系	complete MammoCult培养基	含有成纤维细胞生长因子10、肝细胞生长因子、催乳素的EpiCult B培养基、Matrigel/CollagenⅠ	含有成纤维细胞生长因子10、肝细胞生长因子的EpiCult B培养基、 Matrigel/CollagenⅠ

表1 胚胎干细胞、诱导多能干细胞来源的类器官构建材料

组织类型	组织来源	胚层分化培养基	器官分化培养基	类器官生长培养基
肠^[5]	人源胚胎干细胞和诱导性多能干细胞	含有Activin A的RPMI 1640培养基	含有成纤维细胞生长因子4、 CHIR99021的RPMI 1640培养基	含有表皮细胞生长因子、头蛋白、R-spondin1的高级DMEM/F12培养基、Matrigel
胃^[6]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin A、BMP4的RPMI 1640培养基	WNT3A、CHIR99021、成纤维细胞生长因子4、头蛋白、维甲酸的RPMI 1640培养基	含有表皮细胞生长因子、头蛋白、维甲酸的高级DMEM/F12培养基、 Matrigel
肝脏^[7]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin A、BMP4、CHIR 99021、成纤维细胞生长因子2、 LY294002的DMEM/F12培养基	含有成纤维细胞生长因子10、 BMP4的RPMI及B27培养基	含有肝细胞生长因子、抑瘤素M的高级DMEM/F12培养基、Matrigel
脑^[8]	人源胚胎干细胞和诱导性多能干细胞系	含有endo-IWR1、LDN-193189、 SB431542、β-巯基乙醇的KSR培养基	含有NEAA、BDNF、GDNF的neurobasal-type differentiation培养基、Matrigel	DMEM/F12培养基、Matrigel
肾^[9]	人源胚胎干细胞和诱导性多能干细胞系	含有Activin的高级RPMI培养基	含有成纤维细胞生长因子9、 CHIR99021的高级RPMI培养基	含有CHIR99021、头蛋白、成纤维细胞生长因子9的高级RPMI 1640培养基
肺^[10]	人源胚胎干细胞系	含有Activin A、BMP4的DMEM/ F12培养基	含有成纤维细胞生长因子7，CHIR - 99021、维甲酸的DMEM/ F12培养基	DMEM/F12培养基、Matrigel
乳腺^[11]	人源诱导性多能干细胞系	complete MammoCult培养基	含有成纤维细胞生长因子10、肝细胞生长因子、催乳素的EpiCult B培养基、Matrigel/CollagenⅠ	含有成纤维细胞生长因子10、肝细胞生长因子的EpiCult B培养基、 Matrigel/CollagenⅠ

[1]	Sato T, Vries RG, Snippert HJ，et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature，2009，459(7244):262-265. DOI：10.1038/nature07935.
[2]	Barker N, van Es JH, Kuipers J，et al. Identification of stem cells in small intestine and colon by marker gene Lgr5[J]. Nature，2007，449(7165):1003-1007. DOI：10.1038/nature06196.
[3]	Thomson JA, Itskovitz-Eldor J, Shapiro SS，et al. Embryonic stem cell lines derived from human blastocysts[J]. Science，2008，282(5391):1145-1147. DOI：10.1126/science.282.5391.1145.
[4]	Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell，2006，126(4):663-676. DOI：10.1016/j.cell.2006.07.024.
[5]	Workman MJ, Mahe MM, Trisno S，et al. Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system[J]. Nature Medicine，2016，23(1):49-59. DOI：10.1038/nm.4233.
[6]	McCracken KW, Catá EM, Crawford CM，et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids[J]. Nature，2014，516(7531):400-404. DOI：10.1038/nature13863.
[7]	Guan Y, Xu D, Garfin PM，et al. Human hepatic organoids for the analysis of human genetic diseases[J]. JCI Insight，2017，2(17). DOI：10.1172/jci.insight.94954.
[8]	Li R, Sun L, Fang A，et al. Recapitulating cortical development with organoid culture in vitro，and modeling abnormal spindle-like（ASPM related primary）microcephaly disease[J]. Protein Cell，2017，8(11):823-833. DOI：10.1007/s13238-017-0479-2.
[9]	Morizane R, Lam AQ, Freedman BS，et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury[J]. Nature Biotechnology，2015，33(11):1193-1200. DOI：10.1038/nbt.3392.
[10]	Miller AJ, Hill DR, Nagy MS，et al. In Vitro Induction and In Vivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells[J]. Stem Cell Reports，2018，10(1):101-119. DOI：10.1016/j.stemcr.2017.11.012.
[11]	Ying Q, Han B, Gao B，et al. Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids[J]. Stem Cell Reports，2017，8(2):205-215. DOI：10.1016/j.stemcr.2016.12.023.
[12]	Finkbeiner SR, Hill DR, Altheim CH，et al. Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo[J]. Stem Cell Reports，2015，4(6):1140-1155. DOI：10.1016/j.stemcr.2015.04.010.
[13]	Bartfeld S, Bayram T, van de Wetering M，et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology，2015，148(1):126-136.e6. DOI：10.1053/j.gastro.2014.09.042.
[14]	Huch M, Gehart H, van Boxtel R，et al. Long-term culture of genome-stable bipotent stem cells from adult human liver[J]. Cell，2015，160(1-2):299-312. DOI：10.1016/j.cell.2014.11.050.
[15]	Karthaus WR, Iaquinta PJ, Drost J，et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures[J]. Cell，2014，159(1):163-175. DOI：10.1016/j.cell.2014.08.017.
[16]	Broutier L, Andersson-Rolf A, Hindley CJ，et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation[J]. Nature Protocols，2016，11(9):1724-1743. DOI：10.1038/nprot.2016.097.
[17]	Loomans CJM, Williams Giuliani N, Balak J，et al. Expansion of Adult Human Pancreatic Tissue Yields Organoids Harboring Progenitor Cells with Endocrine Differentiation Potential[J]. Stem Cell Reports，2018，10(3):712-724. DOI：10.1016/j.stemcr.2018.02.005.
[18]	Fulcher ML, Randell SH. Human nasal and tracheo-bronchial respiratory epithelial cell culture[J]. Methods Mol Biol，2013(945):109-121. DOI：10.1007/978-1-62703-125-7_8.
[19]	Linnemann JR, Meixner LK, Miura H，et al. An Organotypic 3D Assay for Primary Human Mammary Epithelial Cells that Recapitulates Branching Morphogenesis[J]. Methods Mol Biol，2017(1612):125-137. DOI：10.1007/978-1-4939-7021-6_9.
[20]	Ozdemir T, Srinivasan PP, Zakheim DR，et al. Bottom-up assembly of salivary gland microtissues for assessing myoepithelial cell function[J]. Biomaterials，2017(142):124-135. DOI：10.1016/j.biomaterials.2017.07.022.
[21]	Srinivasan PP, Patel VN, Liu S，et al. Primary Salivary Human Stem/Progenitor Cells Undergo Microenvironment-Driven Acinar-Like Differentiation in Hyaluronate Hydrogel Culture[J]. Stem Cells Translational Medicine，2017，6(1):110-120. DOI：10.5966/sctm.2016-0083.
[22]	Hisha H, Tanaka T, Kanno S，et al. Establishment of a Novel Lingual Organoid Culture System：Generation of Organoids Having Mature Keratinized Epithelium from Adult Epithelial Stem Cells[J]. Sci Rep，2013(3):3224. DOI：10.1038/srep03224.
[23]	Barbera M, di Pietro M, Walker E，et al. The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation[J]. Gut，2015，64(1):11-19. DOI：10.1136/gutjnl-2013-306171.
[24]	Saito Y, Onishi N, Takami H，et al. Development of a functional thyroid model based on an organoid culture system[J]. Biochem Biophys Res Commun，2018，497(2):783-789. DOI：10.1016/j.bbrc.2018.02.154.
[25]	Kashfi SMH, Almozyan S, Jinks N，et al. Morphological alterations of cultured human colorectal matched tumour and healthy organoids[J]. Oncotarget，2018，9(12):10572-10584. DOI：10.18632/oncotarget.24279.
[26]	Seidlitz T, Merker SR, Rothe A，et al. Human gastric cancer modelling using organoids[J]. Gut，2019，68(2):207-217. DOI：1136/gutjnl-2017-314549.
[27]	Broutier L, Mastrogiovanni G, Verstegen MM，et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J]. Nat Med，2017，23(12):1424-1435. DOI：10.1038/nm.4438.
[28]	Drost J, Karthaus WR, Gao D，et al. Organoid culture systems for prostate epithelial and cancer tissue[J]. Nat Protoc，2016，11(2):347-358. DOI：10.1038/nprot.2016.006.
[29]	Boj SF, Hwang CI, Baker LA，et al. Organoid models of human and mouse ductal pancreatic cancer[J]. Cell，2015，160(1-2):324-338. DOI：10.1016/j.cell.2014.12.021.
[30]	Walsh AJ, Cook RS, Sanders ME，et al. Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer[J]. Cancer Res，2014，74(18):5184-5194. DOI：10.1158/0008-5472.CAN-14-0663.
[31]	Sachs N, Ligt JD, Kopper O，et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity[J]. Cell，2017，172(1-2):373. DOI：10.1016/j.cell.2017.11.010.
[32]	Shah AT, Heaster TM, Skala MC. Metabolic Imaging of Head and Neck Cancer Organoids[J]. PLoS ONE，2017，12(1):e0170415. DOI：10.1371/journal.pone.0170415.
[33]	Nusse R, Clevers H. Wnt/β-Catenin Signaling，Disease，and Emerging Therapeutic Modalities[J]. Cell，2017，169(6):985-999. DOI：10.1016/j.cell.2017.05.016
[34]	Fair KL, Colquhoun J, Hannan NRF. Intestinal organoids for modelling intestinal development and disease[J]. Philosophical Transactions of the Royal Society B：Biological Sciences，2018，373(1750):20170217. DOI：10.1098/rstb.2017.0217.
[35]	Lin LM, Bill K. A review of regenerative endodontics：current protocols and future directions[J]. J Istanb Univ Fac Dent，2017，51(3 Suppl 1):S41-S51. DOI：10.17096/jiufd.53911.

[1]	李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2]	陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3]	许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4]	李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5]	刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6]	任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7]	赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8]	吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9]	周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10]	常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11]	高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12]	徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[13]	王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14]	李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[15]	陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

The research progress of human organoids and the prospects of application in stomatology

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

The research progress of human organoids and the prospects of application in stomatology